GET STARTED WITH OUR PHARMACY PROVIDER

HAVE A QUESTION? GET IN TOUCH

Privacy Policy

Tolmar is committed to protecting your personal privacy. We handle personal information with the utmost respect and assure that all information submitted on the Tolmar site will remain strictly confidential. Tolmar requires that any person or organization providing products and/or services to our clients on our behalf protect the confidentiality of Tolmar’s customer information.

Unless Tolmar receives written permission from an individual, we will not:

  • Sell or rent personal information;
  • Provide personal information to persons or organizations outside of Tolmar and our affiliate business partners;
  • Market personal information to the general public.

The Tolmar site collects only information provided “voluntarily” when using or registering with us on this site. Such information may include:

  • Your Name
  • Position/ Job Title
  • Company Name
  • Street Address
  • City and State
  • Zip Code
  • Telephone Number
  • Email Address

The information gathered from each client is used internally to process proposals, ensure proper billing, service an account and offer other employment related products that may better serve your needs.

Applicability of This Policy

This privacy policy applies only to the information that is collected on Tolmar’s website. It does not apply to any information collected through other methods or sources, including sites owned or operated by our affiliate business partners.

Affiliated Business Partners

Tolmar works closely with affiliated businesses partners that may have links on our website. Please remember that when you use a link to go from Tolmar’s website to another website, our Privacy Policy no longer applies.

Any browsing and interaction on any third party’s website, including any site that has a link on Tolmar’s website, is subject to the policies and rules of that website.

Changes to Policy Statement

Tolmar reserves the right to change, modify, or amend our privacy policy as needed; we intend to maintain a policy that is at the forefront of privacy and security principles. Tolmar takes privacy matters seriously; if there are any changes to our privacy policy statement, we will place an updated version on this page. Tolmar encourages site users and visitors to check our privacy policy regularly to stay informed of any policy updates or changes.

Contact Information

Thank you for choosing Tolmar. We appreciate your business and the opportunity to serve you. If you have any questions, concerns or comments regarding this privacy policy, please feel free to contact Tolmar at:

Tolmar, Inc.
701 Centre Ave
Fort Collins, CO 80526
970-212-4500
1-877-9Tolmar (1-877-986-5627)

California Residents

If you are a California resident, the information below may apply to you in addition to our Privacy Policy. This below information uses certain terms that have the meanings given to them by the California Consumer Privacy Act.

We only share your personal information with the categories of third parties for the business and commercial purposes described below. We do not sell or rent personal information to third parties, including for their own marketing purposes.

Collection and Disclosure

During the past 12 months, we may have:

a. Collected the following categories of personal information about you:

  • Identifiers: identifiers such as a real name, alias, postal address, unique personal identifier (such as customer number, unique pseudonym, or user alias), email address, account name, Social Security number, driver’s license number, passport number, and other similar identifiers, physical characteristics or description, state identification card number, and signature
  • Identifiers (Online): a device identifier; cookies, beacons, pixel tags, mobile ad identifiers and similar technology; other forms of persistent or probabilistic identifiers, and Internet Protocol address
  • Other Financial, Medical, and Health Information: bank account number, credit card number, debit card number, insurance policy number, and other financial information, medical information, and health insurance information
  • Information Related to Characteristics Protected Under California or Federal Law: characteristics of protected classifications under California or federal law, such as race, color, national origin, religion, age, sex, gender, gender identity, gender expression, sexual orientation, marital status, medical condition, ancestry, genetic information, disability, citizenship status, and military and veteran status
  • Commercial Information: including records of personal property, products or services purchased, obtained, or considered, and other purchasing or consuming histories or tendencies
  • Biometric Information: Physiological, biological or behavioral characteristics that can be used alone or in combination with each other to establish individual identity, including DNA, fingerprint, diagnostic or lab results, imagery of the face from which an identifier template can be extracted, and sleep, health, or exercise data that contain identifying information.
  • Internet and Other Electronic Network Activity Information: including, but not limited to, browsing history, search history, and information regarding your interaction with websites, applications or advertisements
  • Geolocation Data: Precise geographic location information about a particular individual or device.
  • Sensory Information: Audio, electronic, visual, thermal, and similar information
  • Professional or Employment-Related Information
  • Education Information
  • Profile Inferences: inferences drawn from any of the information identified above to create a profile about you reflecting your preferences, characteristics, psychological trends, predispositions, behavior, attitudes, intelligence, abilities, and aptitudes

b. Collected personal information about you for the following business or commercial purposes:

  • to respond to your inquiries and to fulfill your requests;
  • to send you important information regarding our relationship with you or regarding this website, changes to our terms, conditions, and policies and/or other administrative information;
  • for audits, to verify that our internal processes function as intended and are compliant with legal, regulatory, or contractual requirements;
  • for fraud or crime prevention, and for technical security monitoring purposes;
  • to facilitate the development of new products and services;
  • to enhance, improve or modify our website or products and services;
  • for data analysis that will allow us to understand website usage trends;
  • to determine the effectiveness of our promotional campaigns, so that we can adapt our campaigns to the needs and interests of our users.
  • to better understand you, so that we can personalize our interactions with you and provide you with information and/or offers tailored to your interests
  • to comply with and enforce applicable legal requirements, relevant industry standards and our policies

c. Shared your personal information with the following categories of third parties:

  • Our affiliates
  • Our joint marketing partners
  • Our business partners
  • Social media networks
  • Third-party marketing partners
  • Government entities

d. Disclosed for a business purpose the following categories of personal information about you:

  • Identifiers
  • Identifiers (Online)
  • Other Financial, Medical and Health Information
  • Information Related to Characteristics Protected Under California or Federal Law
  • Commercial Information
  • Biometrics
  • Internet and Other Electronic Network Activity Information
  • Geolocation Data
  • Sensory Information
  • Professional or Employment-Related Information
  • Education Information
  • Profile Inferences

California Consumer Privacy Rights

Subject to certain exceptions, California residents have the right to make the following requests, at no charge, up to twice every 12 months:

  • Copy: You may request a copy of the specific pieces of personal data that we have collected about you in the prior 12 months and to have this delivered, free of charge, either (a) by mail or (b) electronically in a portable and, to the extent technically feasible, readily useable format that allows you to transmit this information to another entity without hindrance.
  • Deletion: You may request deletion of your personal data that we have collected about you.
  • Know: You may request that we provide you certain information about how we have handled your personal data in the prior 12 months, including the:
    • categories of personal data collected;
    • categories of sources of personal data;
    • business and/or commercial purposes for collecting your personal data;
    • categories of third parties/with whom we have disclosed or shared your personal data; and
    • categories of personal data that we have disclosed or shared with a third party for a business purpose.

We will not discriminate against you for exercising these rights.

Submitting Requests.To exercise your rights please submit a request, or have an authorized agent submit a request on your behalf, to info@tolmar.com or call the following toll-free telephone number 1-844-4TOLMAR. We will respond to your request consistent with applicable law.

IMPORTANT SAFETY INFORMATION FOR JATENZO (testosterone undecanoate)

Indication and Limitations of Use:

JATENZO®(testosterone undecanoate) capsules, CIII, is an androgen indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone:

  • Primary hypogonadism (congenital or acquired)
  • Hypogonadotropic hypogonadism (congenital or acquired)

Safety and efficacy of JATENZO in males less than 18 years old have not been established.

IMPORTANT SAFETY INFORMATION FOR JATENZO (testosterone undecanoate)

WARNING: INCREASES IN BLOOD PRESSURE

  • JATENZO can cause blood pressure (BP) increases that can increase the risk of major adverse cardiovascular events (MACE), including non-fatal myocardial infarction, non-fatal stroke and cardiovascular death.
  • Before initiating JATENZO, consider the patient’s baseline cardiovascular risk and ensure blood pressure is adequately controlled.
  • Periodically monitor for and treat new-onset hypertension or exacerbations of pre-existing hypertension and re-evaluate whether the benefits of JATENZO outweigh its risks in patients who develop cardiovascular risk factors or cardiovascular disease on treatment.
  • Due to this risk, use JATENZO only for the treatment of men with hypogonadal conditions associated with structural or genetic etiologies.

CONTRAINDICATIONS

JATENZO is contraindicated in men with carcinoma of the breast or known or suspected carcinoma of the prostate, in women who are pregnant, in men with a known hypersensitivity to JATENZO or its ingredients, or in men with hypogonadal conditions that are not associated with structural or genetic etiologies.

WARNINGS AND PRECAUTIONS

Increase blood pressure and Major Adverse Cardiovascular Events. JATENZO can increase blood pressure, which can increase the risk of MACE, with greater risk in patients with established cardiovascular disease or risk factors for cardiovascular disease.

Increase in hematocrit and polycythemia. High red blood cell counts increase the risk of clots, strokes, and heart attacks.

Benign prostatic hyperplasia (BPH). Patients may see worsening signs and symptoms of BPH.

Prostate cancer. Patients treated with androgens may be at increased risk for prostate cancer.

Venous thromboembolic events (VTE). Deep vein thrombosis (DVT) and pulmonary embolism (PE) have been reported in patients using testosterone replacement products like JATENZO.

Abuse. Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. Testosterone abuse can lead to serious cardiovascular and psychiatric adverse reactions.

Suppression of spermatogenesis. Large doses of androgens, like JATENZO, can suppress spermatogenesis.

Hepatic adverse events. JATENZO is not known to cause liver adverse events; however, patients should be instructed to report any signs of hepatic dysfunction.

Retention of sodium and water.

Gynecomastia.

Sleep apnea. Testosterone may potentiate sleep apnea in some patients, especially those with risk factors such as obesity or chronic lung disease.

Changes in the serum lipid profile may require dose adjustment of lipid-lowering drugs or discontinuation of testosterone therapy.

Risk of hypercalcemia.

ADVERSE EVENTS

The most common adverse events of JATENZO (incidence ≥2%) are headache (5%), increased hematocrit (5%), hypertension (4%), decreased HDL (3%), and nausea (2%).

DRUG INTERACTIONS

JATENZO can cause changes in insulin sensitivity or glycemic control and changes in anticoagulant activity. Use of testosterone and corticosteroids concurrently may increase fluid retention. Use of prescription and nonprescription analgesic cold medications with JATENZO have been known to increase blood pressure.

Please see full Prescribing Information, including BOXED WARNING on increases in blood pressure.

To report suspected adverse reactions contact Tolmar at 1-844-4TOLMAR (486-5627) or the FDA at 1-800-FDA-1088 or visit www.fda.gov/medwatch.

References

1. JATENZO® [prescribing information]. Fort Collins, CO: Tolmar; 2023.

2. Swerdloff RS, Wang C, White WB, et al. A new oral testosterone undecanoate formulation restores testosterone to normal concentrations in hypogonadal men. J Clin Endocrinol Metab. 2020;105(8):2515-2531.

3. Swerdloff RS, Dudley RE. A new oral testosterone undecanoate therapy comes of age for the treatment of hypogonadal men. Ther Adv Urol. 2020;12:1-16.

4. Data on file. The Landmark SERMO survey: The state of TRT in 2024. (conducted February 16-March 1, 2024). Tolmar, Inc.

5. Data on file. The Harris Poll. Hypogonadism Patient Research: Executive Summary (conducted May 6-June 5, 2020). Tolmar, Inc.

6. Data on file. Clinical Study Report: CLAR-15012. Tolmar, Inc.

7. Petrova TV, Koh GY. Organ-specific lymphatic vasculature: From development to pathophysiology. J Exp Med. 2018;215(1):35-49.

8. Data on file. Clinical Study Report: CLAR-09009. Tolmar, Inc.

9. Data on file. Clinical Study Report: CLAR-09007. Tolmar, Inc.

10. Shoskes JJ, Wilson MK, Spinner ML. Pharmacology of testosterone replacement therapy preparations. Transl Androl Urol. 2016;5(6):834-843.